Metrion welcomes new Sales and Marketing Intern, Anna
Our new Sales and Marketing Intern Anna has written the following piece explaining how she first became interested in the sciences, her aspirations for the future and [...]
An Interview with Damian Bell by Artem Kondratskyi
Introducing Damian Bell: as a new member of the team at Metrion we are using an abridged version of an interview by Artem Kondratskyi for ionchannellibrary.com. A [...]
Improving Cardiac Safety Testing Protocols
Thank you to Dr John Ridley, Metrion Biosciences’ Business Manager for writing this article and to MedNous for publishing this work. This article [...]
Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines
Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines Part of the US [...]
Metrion is open for business
Metrion Biosciences is open to discuss your ion channel drug discovery and safety profiling requirements via info@metrionbiosciences.com. In response to the global COVID-19 outbreak, and to [...]
Metrion’s CEO reflects on participation in Goldman Sachs’ 10,000 Small Businesses UK
During the second half of 2019 Metrion’s CEO Andy Southan spent three months on the Goldman Sachs 10,000 Small Businesses programme. In this blog he reflects on the [...]
Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration
Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research Initial twelve month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimisation phase [...]
Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery
Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special [...]